Orion Oyj Stock price

Equities

ORNBV

FI0009014377

Pharmaceuticals

Market Closed - Nasdaq Helsinki 12:29:45 2024-03-28 pm EDT 5-day change 1st Jan Change
34.57 EUR +0.26% Intraday chart for Orion Oyj +0.29% -11.97%
Sales 2024 * 1.36B 1.47B Sales 2025 * 1.46B 1.58B Capitalization 4.86B 5.24B
Net income 2024 * 229M 247M Net income 2025 * 258M 278M EV / Sales 2024 * 3.58 x
Net Debt 2024 * 4.12M 4.44M Net cash position 2025 * 4.14M 4.47M EV / Sales 2025 * 3.32 x
P/E ratio 2024 *
21.2 x
P/E ratio 2025 *
18.8 x
Employees 3,632
Yield 2024 *
4.81%
Yield 2025 *
4.95%
Free-Float 88.82%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.26%
1 week-1.98%
Current month-5.03%
1 month-6.62%
3 months-12.06%
6 months-4.56%
Current year-11.97%
More quotes
1 week
33.85
Extreme 33.85
34.80
1 month
33.85
Extreme 33.85
37.30
Current year
33.85
Extreme 33.85
45.29
1 year
32.89
Extreme 32.89
47.31
3 years
32.89
Extreme 32.89
55.16
5 years
28.19
Extreme 28.19
55.16
10 years
21.06
Extreme 21.06
58.50
More quotes
Managers TitleAgeSince
Chief Executive Officer 57 98-12-31
Director of Finance/CFO 63 00-12-31
Chief Operating Officer - 15-12-31
Members of the board TitleAgeSince
Chairman 63 21-03-24
Director/Board Member 61 17-03-21
Director/Board Member 54 22-03-22
More insiders
Date Price Change Volume
24-03-28 34.57 +0.26% 236,376
24-03-27 34.48 +0.15% 187,678
24-03-26 34.43 +0.76% 227,307
24-03-25 34.17 -1.81% 174,410
24-03-22 34.8 +0.96% 243,122

Delayed Quote Nasdaq Helsinki, March 28, 2024 at 12:29 pm EDT

More quotes
Orion Oyj is Finland's leading pharmaceutical group. Net sales break down by family products and services as follows: - generic, OTC and biosimilar drugs (43.4%); - patented prescription products (41.7%): notably intended for treating dysfunctions of the nervous system, cardiovascular diseases, hormonal and urological treatments; - animal health products (8.7%); - pharmaceutical ingredients and outsourcing services (6.2%). Net sales break down primarily by source of revenue between sales of products (86.9%) and royalties (10.4%). Net sales are distributed geographically as follows: Finland (28%), Scandinavia (12%), Europe (30.8%), North America (14.7%) and other (14.5%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
6
Last Close Price
34.57 EUR
Average target price
39.9 EUR
Spread / Average Target
+15.42%
Consensus
  1. Stock
  2. Equities
  3. Stock Orion Oyj - Nasdaq Helsinki